HUN-REN Szegedi Biologiai Kutatokozpont

HUN-REN Szegedi Biologiai Kutatokozpont is a research organisation in Szeged, Hungary that has taken part in 11 EU-funded projects since 2021, receiving €6.1M in EU funding and leading 2 as coordinator.

EU funding received€6.1M
EU projects11
As coordinator2
Running now9
First EU project2021
Latest project2026
CountryHungary
EU registration (PIC)866906461
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are HUN-REN Szegedi Biologiai Kutatokozpont's own share of each project, not the project's full budget.

  • Horizon Europe€5.8M · 8 projects
  • Horizon 2020€300k · 2 projects
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

11 EU-funded projects, newest first. HUN-REN Szegedi Biologiai Kutatokozpont led 2 of them as coordinator. Each links to the official record.

  • REPhRAMEPartner

    REcurrent urinary tract infection: Efficacy and safety of PHage theRapy and Microbiota transfEr

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €377ktheir share
  • MetaExplorePartner

    Ultrahigh-throughput exploration of metagenomic sequence space to discover and engineer novel biocatalysts and bioactive compounds

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €510ktheir share
  • ENDAMRPartner

    Exploring Novel Drivers of Anti-Microbial Resistance

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €216ktheir share
  • MiCCrobioTAcklePartner

    Advancing Research at the Intersection Between Gut Microbiota and Cancer Cachexia to Train Europe’s Future Leaders in Microbiota Medicine

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €198ktheir share
  • FutureAntibioticsCoordinator

    Antibiotics of the future: are they prone to bacterial resistance?

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €2.9Mtheir share
  • ID-DarkMatter-NCDPartner

    Unraveling the dark matter of infectious diseases, environmental and genetic factors tipping the balance towards NCDs

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €240ktheir share
  • SWEEPICSPartner

    SWEEPICS: SWEPT LASERS FOR NON-INVASIVE DIAGNOSTICS

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €193ktheir share
  • CONVERGENCECoordinator

    Major transitions made easy? In search of genetic preconditions that help the repeated evolution and loss of fungal multicellularity

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €1.2Mtheir share
  • EUGLOH 2.0Associated partner

    European University Alliance for Global Health - Part 2.0

    Erasmus+ (ERASMUS+) · 2023–2026 · Project on the EU portal ↗

  • FAIR CHARMPartner

    Fast Infrared Coherent Harmonic Microscopy

    Horizon 2020 · 2022–2026 · Project on CORDIS ↗

    €299ktheir share
  • Algae4IBDPartner

    ALGAE4IBD –FROM NATURE TO BEDSIDE- ALGAE BASED BIO COMPOUND FOR PREVENTION AND TREATMENT OF INFLAMMATION, PAIN AND IBD

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

    €1ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • antibiotic resistance
  • antibiotics
  • big data
  • cells technologies
  • computational science
  • coronaviruses
  • dark matter
  • ecosystems
  • gene therapy
  • immunotherapy
  • infectious diseases
  • laser physics
  • machine learning
  • microbiomes

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime